Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis

 

作者: PDHome,   SJPocock,   HBeck-Nielsen,  

 

期刊: Evidence-Based Medicine  （BMJ Available online 2007）
卷期: Volume 12, issue 6  

页码: 170-170

 

ISSN:1473-6810

 

年代: 2007

 

出版商: ebm

 

数据来源: BMJ

 

 

点击下载:  PDF (114KB)

返 回